Key Insights

Highlights

Treatment Research

7 treatments under study, led by Carboplatin

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 1 trials

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed with results

Key Signals

Data Visualizations

Phase Distribution

1Total
Phase 2 (1)

Trial Status

Active Not Recruiting1

Clinical Trials (1)

Research Network

Common Treatments

  • Carboplatin1
  • Oxaliplatin1
  • Gastrectomy1
  • Paclitaxel1
  • Radiotherapy Of Gastric Cancer1

Active Sponsors

  • The Netherlands Cancer Institute1

Top Investigators

Related Conditions

  • Gastric Cancer1

Activity Timeline